CureVac (CVAC) - News Mentions

Sign up to add (CVAC) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 1 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 100%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 1 0%
Analyzing CureVac (NASDAQ:CVAC) and BioHarvest Sciences (NASDAQ:BHST)
March 28
European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps
March 28
CureVac says European Patent Office dismissed BioNTech opposition
March 28
CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions
March 28
European Patent Office declares CureVac mRNA patent valid
March 27
CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
March 27
Amundi Trims Holdings in CureVac (NASDAQ:CVAC)
March 22
CureVac: The mid-term effect of pipeline pruning
February 20
CureVac (NASDAQ:CVAC) Earns “Market Outperform” Rating from JMP Securities
February 16
mRNA Vaccine and Therapeutics Market Report 2025-2035: 430+ Patents Filed, Signaling Robust Growth in mRNA Intellectual Property
April 1
mRNA Patent Wars Update: The Plot Thickens with Key Rulings Expected in 2025
March 23
mRNA Vaccines Market Trends and Competition Analysis 2025-2030: Revenues are Projected to Nearly Double, Growing by ~$8 Billion
March 18
Global Oligonucleotide Synthesis Market to Cross USD 7 Billion by 2032 | DelveInsight
February 25
$16.85 Bn Influenza Vaccines Market Research 2025-2033: Expansion of Production Capacity, Strategic Partnerships and Collaborations, Advancements in Development
February 11
Epitopea Appoints Klaus Edvardsen M.D., Ph.D. as Chief Medical Officer
February 7
Stargate: Trump Partners with Technocrats to Promote mRNA Injections, AI, and Transhumanism
January 29

Month over Month

Est. daily news mentions.

Mar 2025 0
Feb 2025 0
Jan 2025 1

How often is CureVac mentioned in the news?

CureVac was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is CureVac performing compared to its industry peers?

CureVac underperforms its industry peers when it comes to News Mentions, ranking in the 10th percentile.

Has there been an increase or decrease in news mentions of CureVac in the last month?

There has been no significant change in the number of news mentions for CureVac's compared to the last month.

Why is it important to track news mentions for CureVac?

By monitoring mentions in the news for CureVac, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of CureVac, ultimately improving their investment strategies.

Sign up and get more insights on CureVac.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact